Objectives: Identifying patients who would benefit from hereditary cancer genetic testing by
family history alone can miss a significant portion of both BRCA and Lynch mutation
carriers. The purpose of this study is to determine whether population-based testing
with a common hereditary cancer panel in all women regardless of family history is
a cost-effective cancer prevention strategy.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gynecologic OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
